Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review.

Giacomo Dal BelloPaolo GisondiLuca IdolazziGiampiero Girolomoni

Published in: Rheumatology and therapy (2020)

Patients affected by PsA have a higher prevalence of type 2 DM compared with the general population. The mechanism linking PsA with DM has not been completely clarified, but some of the principal mediators could be TNF-α and adipokine, especially adiponectin and omentin. Apremilast and TNF-α inhibitor may have a favorable effect and could be safely used in patients with DM.

Keyphrases

prostate cancer
end stage renal disease
rheumatoid arthritis
glycemic control
ejection fraction
newly diagnosed
chronic kidney disease
metabolic syndrome
peritoneal dialysis
risk factors
radical prostatectomy
type diabetes
insulin resistance
adipose tissue